Back to top
more

Inter Parfums (IPAR)

(Delayed Data from NSDQ)

$120.56 USD

120.56
106,352

-0.40 (-0.33%)

Updated Jun 5, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (160 out of 248)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Altria's (MO) Pricing & Smoke-Free Strength Aid Amid Hurdles

by Zacks Equity Research

Altria (MO) benefits from its smoke-free alternatives and pricing strength amid cost inflation and low cigarette volumes.

McCormick (MKC) Thrives on Strategic Buyouts & Efficiency Plans

by Zacks Equity Research

McCormick (MKC) benefits from its strategic acquisitions and innovative initiatives. Robust efficiency programs also aid amid cost inflation.

Philip Morris' (PM) Pricing, Smoke-Free Forte Aid Amid Hurdles

by Zacks Equity Research

Philip Morris (PM) benefits from its smoke-free alternatives and pricing strength amid cost inflation and low cigarette volumes.

Estee Lauder (EL) Q4 Earnings Beat Estimates, Sales Up Y/Y

by Zacks Equity Research

Estee Lauder's (EL) fourth-quarter fiscal 2023 results reflect strength in nearly all categories other than Skin Care. The company remains well-placed for fiscal 2024.

Zacks.com featured highlights include Inter Parfums, MercadoLibre, Modine Manufacturing, AMETEK and RLI

by Zacks Equity Research

Inter Parfums, MercadoLibre, Modine Manufacturing, AMETEK and RLI are part of the Zacks Screen of the Week article.

Tirthankar Chakraborty headshot

5 Best Stocks to Buy for Remarkable Earnings Growth

by Tirthankar Chakraborty

Invest in stocks like Inter Parfums (IPAR), MercadoLibre (MELI), Modine Manufacturing (MOD), AMETEK (AME) & RLI for solid earnings growth

Wall Street Analysts See a 26.33% Upside in Inter Parfums (IPAR): Can the Stock Really Move This High?

by Zacks Equity Research

The mean of analysts' price targets for Inter Parfums (IPAR) points to a 26.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Inter Parfums (IPAR) Ups '23 EPS Guidance on Q2 Earnings Beat

by Zacks Equity Research

Inter Parfums' (IPAR) second-quarter 2023 results reflect higher earnings and sales on growth across Europe and U.S.-based operations. Management raises the 2023 earnings view.

Inter Parfums (IPAR) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Inter Parfums (IPAR) delivered earnings and revenue surprises of 22.47% and 0.05%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Inter Parfums (IPAR) Queued for Q2 Earnings: Things to Note

by Zacks Equity Research

Inter Parfums' (IPAR) second-quarter 2023 performance will likely reflect gains from the company's brand strength across U.S. and European operations.

Upstart (UPST) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Upstart's (UPST) second-quarter 2023 performance is likely to have benefited from recent additions to its product portfolio amid a challenging macro environment and tightening from funding partners.

Is a Surprise Coming for Inter Parfums (IPAR) This Earnings Season?

by Zacks Equity Research

Inter Parfums (IPAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

3D Systems (DDD) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

3D Systems' (DDD) second-quarter results are likely to reflect strong demand for healthcare products and stabilization in industrial division.

Factors Likely to Drive Purple Innovation's (PRPL) Q2 Earnings

by Zacks Equity Research

Purple Innovation's (PRPL) Q2 results are likely to reflect gains from the innovative product line and efforts to reduce costs amid inflationary pressures and a demand shift.

Medifast (MED) Queued for Q2 Earnings: Things to Consider

by Zacks Equity Research

Medifast's (MED) second-quarter 2023 performance will likely reflect challenges related to customer acquisition and higher cost inflation.

Nu Skin (NUS) Lowers 2023 Guidance Despite Q2 Earnings Beat

by Zacks Equity Research

Nu Skin (NUS) reports sequential improvements in Q2 results, driven by the Mainland China and Rhyz segments. However, macro-economic factors pose challenges in the key markets.

Is Vertiv Holdings (VRT) Likely to Surpass Q2 Earnings Estimates?

by Zacks Equity Research

Vertiv Holdings' (VRT) second-quarter performance is likely to have been aided by solid demand for its digital infrastructure and continuity solutions.

What's on the Cards for Monster Beverage (MNST) in Q2 Earnings?

by Zacks Equity Research

Monster Beverage's (MNST) Q2 results are expected to reflect gains from continued strength in the energy drinks category and robust product innovation plans.

Things You Need to Know Before Corteva's (CTVA) Q2 Earnings

by Zacks Equity Research

A favorable product mix and pricing gains are likely to have contributed to Corteva's (CVTA) Q2 performance. However, currency headwinds and higher input costs are likely to have ailed.

Cloudflare (NET) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Cloudflare's (NET) second-quarter performance is likely to have been aided by solid demand for security solutions and the benefits of its recurring subscription-based business model.

Fortinet (FTNT) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Fortinet's (FTNT) second-quarter 2023 earnings are likely to have been aided by the strong adoption of Security Fabric, cloud and SD-WAN offerings.

Procter & Gamble (PG) Rises on Q4 Earnings Beat, Robust View

by Zacks Equity Research

Procter & Gamble's (PG) Q4 results reflect strong gains from its pricing actions, robust demand, improved sales and margins, and a positive product mix.

Inter Parfums (IPAR) Ups 2023 Guidance on Robust Q2 Sales

by Zacks Equity Research

Inter Parfums' (IPAR) sales increase year over year in second-quarter 2023. Management raises its top-line view for 2023.

COTY Inks Agreement to Offload 3.6% of Its Stake in Wella

by Zacks Equity Research

COTY inks a letter of intent to divest part of its stake in Wella to IGF Wealth Management. This is likely to help the company meet its leverage goal toward 3X as it exits CY23.

Inter Parfums (IPAR) Gains on Partnerships & Product Launches

by Zacks Equity Research

Inter Parfums (IPAR) focuses on product launches to boost brand strength. The company's strength in strategic partnerships is driving growth.